Kratos Defense & Security Solutions, Inc. (KTOS) stock
Close on Nov 17, 2026Market cap $5.83BP/E 182.7Yield –
Earnings
Kratos Defense & Security Solutions's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Kratos Defense & Security Solutions's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 28, 2026 | Feb 22, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 27, 2026 | Nov 5, 2026after the close | $471.80M | +35.7% | $0.00 | $0.24 | Release |
| Q2 FY2026ended Jun 28, 2026 | Aug 4, 2026after the close | $458.80M | +30.5% | – | $0.21 | Release |
| Q1 FY2026ended Mar 29, 2026 | May 6, 2026after the close | $371.00M | +22.6% | – | $0.16 | Release |
| Q4 FY2025ended Dec 28, 2025 | Feb 23, 2026after the close | $345.10M | +21.9% | $0.03 | $0.18 | Release |
| Q3 FY2025ended Sep 28, 2025 | Nov 4, 2025after the close | $347.60M | +26.0% | $0.05 | $0.14 | Release |
| Q2 FY2025ended Jun 29, 2025 | Aug 7, 2025after the close | $351.50M | +17.1% | $0.02 | $0.11 | Release |
| Q1 FY2025ended Mar 30, 2025 | May 7, 2025after the close | $302.60M | +9.2% | $0.03 | $0.12 | Release |
| Q4 FY2024ended Dec 29, 2024 | Feb 26, 2025after the close | $283.10M | +3.4% | $0.03 | $0.13 | Release |
| Q3 FY2024ended Sep 29, 2024 | Nov 7, 2024after the close | $275.90M | +0.5% | $0.02 | $0.11 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024after the close | $300.10M | +16.8% | $0.05 | $0.14 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 7, 2024after the close | $277.20M | +19.6% | $0.01 | $0.11 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 13, 2024after the close | $273.80M | +9.8% | $0.02 | $0.12 | Release |
| Q3 FY2023ended Oct 1, 2023 | Nov 2, 2023after the close | $274.60M | +20.1% | -$0.01 | $0.12 | Release |
| Q2 FY2023ended Jun 25, 2023 | Aug 3, 2023after the close | $256.90M | +14.6% | -$0.02 | $0.09 | Release |
| Q1 FY2023ended Mar 26, 2023 | May 3, 2023after the close | $231.80M | +18.1% | -$0.05 | $0.06 | Release |
| Q4 FY2022ended Dec 25, 2022 | Feb 23, 2023after the close | $249.30M | +17.8% | -$0.07 | $0.08 | Release |
| Q3 FY2022ended Sep 25, 2022 | Nov 3, 2022after the close | $228.60M | +14.0% | -$0.06 | $0.08 | Release |
| Q2 FY2022ended Jun 26, 2022 | Aug 4, 2022after the close | $224.20M | – | -$0.04 | $0.07 | Release |
| Q1 FY2022ended Mar 27, 2022 | May 5, 2022after the close | $196.20M | – | -$0.12 | $0.04 | Release |
| Q4 FY2021ended Dec 26, 2021 | Feb 22, 2022after the close | $211.60M | – | -$0.02 | $0.11 | Release |
| Q3 FY2021ended Sep 26, 2021 | Nov 3, 2021after the close | $200.60M | – | -$0.02 | $0.09 | Release |
| Q2 FY2021ended Jun 27, 2021 | Aug 3, 2021after the close | – | – | – | – | Filing |
| Q1 FY2021ended Mar 28, 2021 | May 5, 2021after the close | – | – | – | – | Filing |
| Q4 FY2020ended Dec 27, 2020 | Feb 25, 2021after the close | – | – | – | – | Filing |
| Q3 FY2020ended Sep 27, 2020 | Oct 29, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Kratos Defense & Security Solutions's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| organic growthnon-GAAP | Q4 FY2026 | +19% – +31% | – | New | Aug 4, 2026 |
| organic revenue growthnon-GAAP | FY2026 | +18% – +23% | +15% – +20% | Raised | Aug 4, 2026 |
| organic revenue growth | FY2026 | +15% – +20% | – | New | Feb 23, 2026 |
| Revenue Growth | FY2026 | +13% – +15% | – | New | Feb 26, 2025 |
| Revenues | FY2026 | $1.70B – $1.76B | $1.60B – $1.68B | Raised | May 6, 2026 |
| Operating Income (loss)GAAP | FY2026 | $18.00M – $23.00M | $55.00M – $60.00M | Lowered | May 6, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $170.00M – $176.00M | $157.00M – $167.00M | Raised | May 6, 2026 |
| Free Cash Flow Usenon-GAAP | FY2026 | -$105.00M – -$85.00M | -$105.00M – -$85.00M | Reaffirmed | Aug 4, 2026 |
| Capital Expenditures | FY2026 | $125.00M – $135.00M | $155.00M – $165.00M | Lowered | Aug 4, 2026 |
| Adjusted EBITDA Forecast or % of Revenuenon-GAAP | FY2026 | 9.9% – 10% | – | New | Feb 23, 2026 |
| Amortization | FY2026 | $43.00M – $46.00M | – | Lowered | May 6, 2026 |
| Depreciation | FY2026 | $48.00M – $50.00M | – | Lowered | May 6, 2026 |
| Operating Cash Flow | FY2026 | $30.00M – $50.00M | $60.00M – $70.00M | Lowered | Aug 4, 2026 |
| organic revenue growthnon-GAAP | FY2026 | +14% | – | New | May 7, 2025 |
| R&D | FY2026 | $50.00M – $53.00M | – | Lowered | May 6, 2026 |
| Stock Based Compensation | FY2026 | $58.00M – $60.00M | – | Raised | May 6, 2026 |
| 2027 full year organic revenue growth rate targetnon-GAAP | FY2027 | +18% – +23% | – | New | Nov 4, 2025 |
| organic revenue growth | FY2027 | +18% – +23% | – | New | Feb 23, 2026 |
Guidance vs results
The last range Kratos Defense & Security Solutions gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Revenue | $460.00M – $480.00M | $471.80M | Within range |
| Q2 FY2026 | Revenue | $400.00M – $410.00M | $458.80M | Above range |
| Q1 FY2026 | Revenue | $335.00M – $345.00M | $371.00M | Above range |
| FY2025 | Revenue | $1.32B – $1.33B | $1.35BΣ4Q | Above range |
| Q4 FY2025 | Revenue | $320.00M – $330.00M | $345.10M | Above range |
| Q3 FY2025 | Revenue | $315.00M – $325.00M | $347.60M | Above range |
| Q2 FY2025 | Revenue | $300.00M – $310.00M | $351.50M | Above range |
| Q1 FY2025 | Revenue | $285.00M – $295.00M | $302.60M | Above range |
| Q4 FY2024 | Revenue | $270.00M – $295.00M | $283.10M | Within range |
| Q3 FY2024 | Revenue | $265.00M – $280.00M | $275.90M | Within range |
| Q2 FY2024 | Revenue | $265.00M – $280.00M | $300.10M | Above range |
| Q1 FY2024 | Revenue | $240.00M – $260.00M | $277.20M | Above range |
| Q4 FY2023 | Revenue | $237.00M – $257.00M | $273.80M | Above range |
| Q3 FY2023 | Revenue | $240.00M – $260.00M | $274.60M | Above range |
| Q2 FY2023 | Revenue | $230.00M – $240.00M | $256.90M | Above range |
| Q1 FY2023 | Revenue | $220.00M – $230.00M | $231.80M | Above range |
| Q4 FY2022 | Revenue | $231.00M – $251.00M | $249.30M | Within range |
| Q3 FY2022 | Revenue | $220.00M – $230.00M | $228.60M | Within range |
| Q2 FY2022 | Revenue | $205.00M – $215.00M | $224.20M | Above range |
| Q1 FY2022 | Revenue | $190.00M – $200.00M | $196.20M | Within range |
| Q4 FY2021 | Revenue | $205.00M – $215.00M | $211.60M | Within range |
Guidance history
Every forecast Kratos Defense & Security Solutions put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 4, 2026 | Capital Expenditures | FY2026 | $125.00M – $135.00M | Lowered |
| Aug 4, 2026 | Adjusted EBITDA | Q3 FY2026 | $40.00M – $45.00M | New |
| Aug 4, 2026 | Free Cash Flow Use | FY2026 | -$105.00M – -$85.00M | Reaffirmed |
| Aug 4, 2026 | Operating Income | Q3 FY2026 | $1.00M – $4.00M | New |
| Aug 4, 2026 | Operating Cash Flow | FY2026 | $30.00M – $50.00M | Lowered |
| Aug 4, 2026 | R&D | Q3 FY2026 | $13.00M – $15.00M | New |
| Aug 4, 2026 | Depreciation | Q3 FY2026 | $11.00M – $12.00M | Lowered |
| Aug 4, 2026 | Amortization | Q3 FY2026 | $12.00M – $13.00M | Raised |
| Aug 4, 2026 | Stock Based Compensation | Q3 FY2026 | $16.00M – $17.00M | Raised |
| Aug 4, 2026 | organic revenue growth | FY2026 | +18% – +23% | Raised |
| Aug 4, 2026 | organic growth | Q3 FY2026 | +19% – +25% | New |
| Aug 4, 2026 | Revenues | Q3 FY2026 | $460.00M – $480.00M | New |
| Aug 4, 2026 | organic growth | Q4 FY2026 | +19% – +31% | New |
| May 6, 2026 | Capital Expenditures | FY2026 | $155.00M – $165.00M | Raised |
| May 6, 2026 | Adjusted EBITDA | FY2026 | $170.00M – $176.00M | Raised |
| May 6, 2026 | Adjusted EBITDA | Q2 FY2026 | $30.00M – $35.00M | New |
| May 6, 2026 | Free Cash Flow Use | FY2026 | -$105.00M – -$85.00M | Lowered |
| May 6, 2026 | Operating Income (loss) | FY2026 | $18.00M – $23.00M | Lowered |
| May 6, 2026 | Operating Income (loss) | Q2 FY2026 | -$8.00M – -$6.00M | New |
| May 6, 2026 | Operating Cash Flow | FY2026 | $60.00M – $70.00M | Raised |
| May 6, 2026 | R&D | FY2026 | $50.00M – $53.00M | Lowered |
| May 6, 2026 | Depreciation | FY2026 | $48.00M – $50.00M | Lowered |
| May 6, 2026 | Amortization | FY2026 | $43.00M – $46.00M | Lowered |
| May 6, 2026 | Stock Based Compensation | FY2026 | $58.00M – $60.00M | Raised |
| May 6, 2026 | R&D | Q2 FY2026 | $12.00M – $14.00M | New |
| May 6, 2026 | Depreciation | Q2 FY2026 | $11.00M – $12.00M | Lowered |
| May 6, 2026 | Amortization | Q2 FY2026 | $12.00M – $13.00M | Raised |
| May 6, 2026 | Stock Based Compensation | Q2 FY2026 | $15.00M – $16.00M | Raised |
| May 6, 2026 | Revenues | FY2026 | $1.70B – $1.76B | Raised |
| May 6, 2026 | Revenues | Q2 FY2026 | $400.00M – $410.00M | New |
| Feb 23, 2026 | Capital Expenditures | FY2026 | $135.00M – $145.00M | New |
| Feb 23, 2026 | Adjusted EBITDA | FY2026 | $157.00M – $167.00M | New |
| Feb 23, 2026 | Adjusted EBITDA | Q1 FY2026 | $25.00M – $30.00M | New |
| Feb 23, 2026 | Free Cash Flow Use | FY2026 | -$95.00M – -$85.00M | New |
| Feb 23, 2026 | Operating Income | FY2026 | $55.00M – $60.00M | New |
| Feb 23, 2026 | Operating Income | Q1 FY2026 | $2.00M – $4.00M | New |
| Feb 23, 2026 | Adjusted EBITDA Forecast or % of Revenue | FY2026 | 9.9% – 10% | New |
| Feb 23, 2026 | Operating Cash Flow | FY2026 | $50.00M – $60.00M | New |
| Feb 23, 2026 | organic revenue growth | FY2026 | +15% – +20% | New |
| Feb 23, 2026 | Revenues | FY2026 | $1.60B – $1.68B | New |
| Feb 23, 2026 | Revenues | Q1 FY2026 | $335.00M – $345.00M | Raised |
| Feb 23, 2026 | organic revenue growth | FY2027 | +18% – +23% | New |
| Nov 4, 2025 | Capital Expenditures | FY2025 | $105.00M – $115.00M | New |
| Nov 4, 2025 | Adjusted EBITDA | FY2025 | $114.00M – $120.00M | New |
| Nov 4, 2025 | Adjusted EBITDA | Q4 FY2025 | $29.00M – $34.00M | New |
| Nov 4, 2025 | Free Cash Flow Use | FY2025 | -$105.00M – -$95.00M | New |
| Nov 4, 2025 | Operating Income | FY2025 | $26.00M – $30.00M | New |
| Nov 4, 2025 | Operating Income | Q4 FY2025 | $5.00M – $10.00M | New |
| Nov 4, 2025 | R&D | FY2025 | $40.00M – $42.00M | New |
| Nov 4, 2025 | Depreciation | FY2025 | $37.00M – $38.00M | Lowered |
| Nov 4, 2025 | Amortization | FY2025 | $13.00M – $14.00M | Lowered |
| Nov 4, 2025 | Stock Based Compensation | FY2025 | $35.00M – $36.00M | Raised |
| Nov 4, 2025 | Operating Cash Flow | FY2025 | $10.00M – $20.00M | Lowered |
| Nov 4, 2025 | R&D | Q4 FY2025 | $10.00M – $11.00M | New |
| Nov 4, 2025 | Depreciation | Q4 FY2025 | $10.00M – $11.00M | Reaffirmed |
| Nov 4, 2025 | Amortization | Q4 FY2025 | $3.00M – $4.00M | Lowered |
| Nov 4, 2025 | Stock Based Compensation | Q4 FY2025 | $8.00M – $9.00M | Raised |
| Nov 4, 2025 | Revenues | FY2025 | $1.32B – $1.33B | New |
| Nov 4, 2025 | Revenues | Q4 FY2025 | $320.00M – $330.00M | New |
| Nov 4, 2025 | full year 2026 organic revenue growth forecast | FY2026 | +15% – +20% | New |
| Nov 4, 2025 | revenue range | Q1 FY2026 | $330.00M – $340.00M | New |
| Nov 4, 2025 | 2027 full year organic revenue growth rate target | FY2027 | +18% – +23% | New |
| Aug 7, 2025 | Capital Expenditures | FY2025 | $125.00M – $135.00M | Reaffirmed |
| Aug 7, 2025 | Adjusted EBITDA | Q3 FY2025 | $25.00M – $30.00M | New |
| Aug 7, 2025 | Adjusted EBITDA | FY2025 | $114.00M – $120.00M | Raised |
| Aug 7, 2025 | Free Cash Flow Use | FY2025 | -$85.00M – -$75.00M | Reaffirmed |
| Aug 7, 2025 | Operating Income | Q3 FY2025 | $3.00M – $7.00M | New |
| Aug 7, 2025 | Operating Income | FY2025 | $29.00M – $34.00M | Lowered |
| Aug 7, 2025 | R&D | Q3 FY2025 | $10.00M – $11.00M | New |
| Aug 7, 2025 | Depreciation | Q3 FY2025 | $9.00M – $10.00M | Lowered |
| Aug 7, 2025 | Amortization | Q3 FY2025 | $3.00M – $4.00M | Lowered |
| Aug 7, 2025 | Stock Based Compensation | Q3 FY2025 | $8.00M – $9.00M | Raised |
| Aug 7, 2025 | R&D | FY2025 | $40.00M – $42.00M | Lowered |
| Aug 7, 2025 | Depreciation | FY2025 | $35.00M – $38.00M | Lowered |
| Aug 7, 2025 | Amortization | FY2025 | $12.00M – $14.00M | Lowered |
| Aug 7, 2025 | Stock Based Compensation | FY2025 | $34.00M – $36.00M | Raised |
| Aug 7, 2025 | Operating Cash Flow | FY2025 | $50.00M – $60.00M | Raised |
| Aug 7, 2025 | Revenues | Q3 FY2025 | $315.00M – $325.00M | New |
| Aug 7, 2025 | Revenues | FY2025 | $1.29B – $1.31B | Raised |
| May 7, 2025 | Capital Expenditures | FY2025 | $125.00M – $135.00M | Reaffirmed |
| May 7, 2025 | Adjusted EBITDA | Q2 FY2025 | $21.00M – $25.00M | New |
| May 7, 2025 | Adjusted EBITDA | FY2025 | $112.00M – $118.00M | Reaffirmed |
| May 7, 2025 | Free Cash Flow Use | FY2025 | -$85.00M – -$75.00M | Reaffirmed |
| May 7, 2025 | Operating Income | Q2 FY2025 | $3.00M – $5.00M | New |
| May 7, 2025 | Operating Income | FY2025 | $34.00M – $39.00M | New |
| May 7, 2025 | R&D | Q2 FY2025 | $9.00M – $10.00M | New |
| May 7, 2025 | Depreciation | Q2 FY2025 | $8.00M – $9.00M | Lowered |
| May 7, 2025 | Amortization | Q2 FY2025 | $3.00M – $4.00M | Lowered |
| May 7, 2025 | Stock Based Compensation | Q2 FY2025 | $7.00M – $8.00M | Raised |
| May 7, 2025 | organic revenue growth | FY2025 | +10% | New |
| May 7, 2025 | R&D | FY2025 | $40.00M – $42.00M | Raised |
| May 7, 2025 | Depreciation | FY2025 | $35.00M – $37.00M | Lowered |
| May 7, 2025 | Amortization | FY2025 | $12.00M – $13.00M | Lowered |
| May 7, 2025 | Stock Based Compensation | FY2025 | $31.00M – $32.00M | Raised |
| May 7, 2025 | Operating Cash Flow | FY2025 | $50.00M – $60.00M | Raised |
| May 7, 2025 | organic revenue growth | FY2026 | +14% | New |
| May 7, 2025 | Revenues | Q2 FY2025 | $300.00M – $310.00M | New |
| May 7, 2025 | Revenues | FY2025 | $1.26B – $1.29B | Reaffirmed |
| Feb 26, 2025 | Capital Expenditures | FY2025 | $125.00M – $135.00M | New |
| Feb 26, 2025 | Adjusted EBITDA | Q1 FY2025 | $20.00M – $24.00M | New |
| Feb 26, 2025 | Adjusted EBITDA | FY2025 | $112.00M – $118.00M | New |
| Feb 26, 2025 | Free Cash Flow Use | FY2025 | -$85.00M – -$75.00M | New |
| Feb 26, 2025 | Operating Income | Q1 FY2025 | $2.00M – $4.00M | New |
| Feb 26, 2025 | Operating Income | FY2025 | $34.00M – $39.00M | New |
| Feb 26, 2025 | R&D | Q1 FY2025 | $10.00M – $11.00M | New |
| Feb 26, 2025 | Depreciation | Q1 FY2025 | $9.00M – $10.00M | Lowered |
| Feb 26, 2025 | Amortization | Q1 FY2025 | $2.00M – $3.00M | Lowered |
| Feb 26, 2025 | Stock Based Compensation | Q1 FY2025 | $7.00M – $8.00M | Raised |
| Feb 26, 2025 | Operating Cash Flow | FY2025 | $50.00M – $60.00M | New |
| Feb 26, 2025 | R&D | FY2025 | $42.00M – $45.00M | Lowered |
| Feb 26, 2025 | Depreciation | FY2025 | $38.00M – $40.00M | Lowered |
| Feb 26, 2025 | Amortization | FY2025 | $9.00M – $11.00M | Lowered |
| Feb 26, 2025 | Stock Based Compensation | FY2025 | $28.00M – $29.00M | Raised |
| Feb 26, 2025 | Revenues | Q1 FY2025 | $285.00M – $295.00M | New |
| Feb 26, 2025 | Organic Revenue Growth | FY2025 | +10% | Reaffirmed |
| Feb 26, 2025 | Revenues | FY2025 | $1.26B – $1.29B | New |
| Feb 26, 2025 | Revenue Growth | FY2026 | +13% – +15% | New |
| Nov 7, 2024 | Capital Expenditures | FY2024 | $60.00M – $70.00M | New |
| Nov 7, 2024 | Adjusted EBITDA | FY2024 | $102.00M – $107.00M | Reaffirmed |
| Nov 7, 2024 | Adjusted EBITDA | Q4 FY2024 | $21.00M – $26.00M | New |
| Nov 7, 2024 | Free Cash Flow Use | FY2024 | -$30.00M – -$10.00M | Reaffirmed |
| Nov 7, 2024 | Operating Income | Q4 FY2024 | $3.00M – $7.00M | New |
| Nov 7, 2024 | Operating Income | FY2024 | $30.00M – $35.00M | New |
| Nov 7, 2024 | R&D | Q4 FY2024 | $10.00M – $11.00M | New |
| Nov 7, 2024 | R&D | FY2024 | $40.00M – $42.00M | New |
| Nov 7, 2024 | Operating Cash Flow | FY2024 | $40.00M – $50.00M | Raised |
| Nov 7, 2024 | Revenues | FY2024 | $1.13B – $1.15B | New |
| Nov 7, 2024 | base case Revenue growth | FY2025 | +10% | New |
| Nov 7, 2024 | Revenues | Q4 FY2024 | $270.00M – $295.00M | New |
| Aug 7, 2024 | Capital Expenditures | FY2024 | $70.00M – $80.00M | Reaffirmed |
| Aug 7, 2024 | Adjusted EBITDA | Q3 FY2024 | $20.00M – $23.00M | New |
| Aug 7, 2024 | Adjusted EBITDA | FY2024 | $102.00M – $107.00M | Reaffirmed |
| Aug 7, 2024 | Free Cash Flow Use | FY2024 | -$30.00M – -$10.00M | Reaffirmed |
| Aug 7, 2024 | Operating Income | Q3 FY2024 | $3.00M – $5.00M | New |
| Aug 7, 2024 | Operating Income | FY2024 | $33.00M – $38.00M | Lowered |
| Aug 7, 2024 | R&D | FY2024 | $40.00M – $43.00M | Lowered |
| Aug 7, 2024 | R&D | Q3 FY2024 | $10.00M – $12.00M | New |
| Aug 7, 2024 | Depreciation | Q3 FY2024 | $7.00M – $8.00M | Lowered |
| Aug 7, 2024 | Amortization | Q3 FY2024 | $2.00M – $3.00M | Lowered |
| Aug 7, 2024 | Stock Based Compensation | Q3 FY2024 | $6.00M – $7.00M | Raised |
| Aug 7, 2024 | Depreciation | FY2024 | $30.00M – $32.00M | Lowered |
| Aug 7, 2024 | Amortization | FY2024 | $8.00M – $10.00M | Lowered |
| Aug 7, 2024 | Stock Based Compensation | FY2024 | $29.00M – $30.00M | Raised |
| Aug 7, 2024 | Operating Cash Flow | FY2024 | $50.00M – $60.00M | Raised |
| Aug 7, 2024 | Revenues | Q3 FY2024 | $265.00M – $280.00M | New |
| Aug 7, 2024 | Revenues | FY2024 | $1.13B – $1.15B | Reaffirmed |
| May 7, 2024 | Capital Expenditures | FY2024 | $70.00M – $80.00M | Reaffirmed |
| May 7, 2024 | Adjusted EBITDA | FY2024 | $102.00M – $107.00M | Reaffirmed |
| May 7, 2024 | Adjusted EBITDA | Q2 FY2024 | $20.00M – $23.00M | New |
| May 7, 2024 | Free Cash Flow Use | FY2024 | -$30.00M – -$10.00M | Reaffirmed |
| May 7, 2024 | Operating Income | Q2 FY2024 | $3.00M – $5.00M | New |
| May 7, 2024 | Operating Income | FY2024 | $35.00M – $40.00M | Lowered |
| May 7, 2024 | Stock Based Compensation | FY2024 | $28.00M – $29.00M | Raised |
| May 7, 2024 | Operating Cash Flow | FY2024 | $50.00M – $60.00M | Raised |
| May 7, 2024 | R&D | Q2 FY2024 | $10.00M – $12.00M | New |
| May 7, 2024 | Depreciation | Q2 FY2024 | $7.00M – $8.00M | Lowered |
| May 7, 2024 | Amortization | Q2 FY2024 | $2.00M – $3.00M | Lowered |
| May 7, 2024 | Stock Based Compensation | Q2 FY2024 | $6.00M – $7.00M | Raised |
| May 7, 2024 | R&D | FY2024 | $42.00M – $45.00M | Raised |
| May 7, 2024 | Depreciation | FY2024 | $30.00M – $31.00M | Lowered |
| May 7, 2024 | Amortization | FY2024 | $8.00M – $10.00M | Lowered |
| May 7, 2024 | Revenues | FY2024 | $1.13B – $1.15B | Reaffirmed |
| May 7, 2024 | Revenues | Q2 FY2024 | $265.00M – $280.00M | New |
| Feb 13, 2024 | Capital Expenditures | FY2024 | $70.00M – $80.00M | New |
| Feb 13, 2024 | Adjusted EBITDA | Q1 FY2024 | $16.00M – $18.00M | New |
| Feb 13, 2024 | Adjusted EBITDA | FY2024 | $102.00M – $107.00M | New |
| Feb 13, 2024 | Free Cash Flow Use | FY2024 | -$30.00M – -$10.00M | New |
| Feb 13, 2024 | Operating Income | FY2024 | $37.00M – $41.00M | New |
| Feb 13, 2024 | Operating Income | Q1 FY2024 | $1.00M – $3.00M | New |
| Feb 13, 2024 | Stock Based Compensation | Q1 FY2024 | $6.00M – $7.00M | Raised |
| Feb 13, 2024 | Depreciation | Q1 FY2024 | $6.00M – $8.00M | Lowered |
| Feb 13, 2024 | R&D | Q1 FY2024 | $9.00M – $11.00M | New |
| Feb 13, 2024 | Amortization | Q1 FY2024 | $2.00M – $3.00M | Lowered |
| Feb 13, 2024 | Stock Based Compensation | FY2024 | $26.00M – $28.00M | Raised |
| Feb 13, 2024 | Amortization | FY2024 | $8.00M – $10.00M | Lowered |
| Feb 13, 2024 | Depreciation | FY2024 | $28.00M – $30.00M | Lowered |
| Feb 13, 2024 | R&D | FY2024 | $42.00M – $45.00M | Lowered |
| Feb 13, 2024 | Operating Cash Flow | FY2024 | $50.00M – $60.00M | New |
| Feb 13, 2024 | Revenues | FY2024 | $1.13B – $1.15B | New |
| Feb 13, 2024 | Revenues | Q1 FY2024 | $240.00M – $260.00M | New |
| Feb 13, 2024 | Organic Revenue Growth | FY2024 | +10% | New |
| Nov 2, 2023 | Capital Expenditures | FY2023 | $45.00M – $50.00M | Reaffirmed |
| Nov 2, 2023 | Adjusted EBITDA | FY2023 | $85.00M – $89.00M | Reaffirmed |
| Nov 2, 2023 | Adjusted EBITDA | Q4 FY2023 | $19.00M – $23.00M | New |
| Nov 2, 2023 | Free Cash Flow Use | FY2023 | -$25.00M – -$20.00M | Lowered |
| Nov 2, 2023 | Operating Income | FY2023 | $25.00M – $28.00M | Raised |
| Nov 2, 2023 | Operating Income | Q4 FY2023 | $4.00M – $7.00M | New |
| Nov 2, 2023 | Amortization | FY2023 | $8.00M – $10.00M | Lowered |
| Nov 2, 2023 | R&D | FY2023 | $40.00M – $42.00M | Lowered |
| Nov 2, 2023 | Stock Based Compensation | Q4 FY2023 | $6.00M – $7.00M | Raised |
| Nov 2, 2023 | Amortization | Q4 FY2023 | $2.00M – $3.00M | Lowered |
| Nov 2, 2023 | Depreciation | Q4 FY2023 | $7.00M – $8.00M | Lowered |
| Nov 2, 2023 | R&D | Q4 FY2023 | $9.00M – $10.00M | New |
| Nov 2, 2023 | Stock Based Compensation | FY2023 | $24.00M – $26.00M | Raised |
| Nov 2, 2023 | Operating Cash Flow | FY2023 | $20.00M – $30.00M | Reaffirmed |
| Nov 2, 2023 | Depreciation | FY2023 | $27.00M – $28.00M | Lowered |
| Nov 2, 2023 | Revenues | FY2023 | $1.00B – $1.02B | Raised |
| Nov 2, 2023 | revenue growth | FY2024 | +10% | New |
| Nov 2, 2023 | Revenues | Q4 FY2023 | $237.00M – $257.00M | New |
| Aug 3, 2023 | Capital Expenditures | FY2023 | $45.00M – $50.00M | Reaffirmed |
| Aug 3, 2023 | Adjusted EBITDA | Q3 FY2023 | $18.00M – $22.00M | New |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $85.00M – $89.00M | Reaffirmed |
| Aug 3, 2023 | Free Cash Flow Generation | FY2023 | $10.00M – $20.00M | Reaffirmed |
| Aug 3, 2023 | Operating Income | FY2023 | $24.00M – $28.00M | Raised |
| Aug 3, 2023 | Operating Income | Q3 FY2023 | $3.00M – $6.00M | New |
| Aug 3, 2023 | Stock Based Compensation | Q3 FY2023 | $6.00M – $7.00M | Raised |
| Aug 3, 2023 | Depreciation | Q3 FY2023 | $7.00M – $8.00M | Lowered |
| Aug 3, 2023 | R&D | Q3 FY2023 | $9.00M – $10.00M | New |
| Aug 3, 2023 | Amortization | Q3 FY2023 | $2.00M – $3.00M | Lowered |
| Aug 3, 2023 | Operating Cash Flow | FY2023 | $55.00M – $65.00M | Raised |
| Aug 3, 2023 | Stock Based Compensation | FY2023 | $24.00M – $26.00M | Raised |
| Aug 3, 2023 | Amortization | FY2023 | $8.00M – $10.00M | Lowered |
| Aug 3, 2023 | Depreciation | FY2023 | $27.00M – $28.00M | Lowered |
| Aug 3, 2023 | R&D | FY2023 | $38.00M – $39.00M | Lowered |
| Aug 3, 2023 | Revenues | FY2023 | $980.00M – $1.00B | Reaffirmed |
| Aug 3, 2023 | Revenues | Q3 FY2023 | $240.00M – $260.00M | New |
| May 3, 2023 | Capital Expenditures | FY2023 | $45.00M – $50.00M | New |
| May 3, 2023 | Adjusted EBITDA | FY2023 | $85.00M – $89.00M | Reaffirmed |
| May 3, 2023 | Adjusted EBITDA | Q2 FY2023 | $14.00M – $18.00M | New |
| May 3, 2023 | Free Cash Flow Generation | FY2023 | $10.00M – $20.00M | Reaffirmed |
| May 3, 2023 | Operating Income | FY2023 | $25.00M – $29.00M | New |
| May 3, 2023 | Operating Income | Q2 FY2023 | $0 – $3.00M | New |
| May 3, 2023 | Depreciation | FY2023 | $26.00M – $28.00M | Lowered |
| May 3, 2023 | Stock Based Compensation | Q2 FY2023 | $6.00M – $7.00M | Raised |
| May 3, 2023 | Amortization | Q2 FY2023 | $2.00M – $3.00M | Lowered |
| May 3, 2023 | Depreciation | Q2 FY2023 | $6.00M – $7.00M | Lowered |
| May 3, 2023 | R&D | Q2 FY2023 | $9.00M – $10.00M | New |
| May 3, 2023 | Amortization | FY2023 | $7.00M – $10.00M | Lowered |
| May 3, 2023 | Stock Based Compensation | FY2023 | $23.00M – $26.00M | Raised |
| May 3, 2023 | Operating Cash Flow | FY2023 | $55.00M – $65.00M | Raised |
| May 3, 2023 | R&D | FY2023 | $36.00M – $39.00M | New |
| May 3, 2023 | Revenues | FY2023 | $980.00M – $1.00B | New |
| May 3, 2023 | Revenues | Q2 FY2023 | $230.00M – $240.00M | New |
| Feb 23, 2023 | Capital Expenditures | FY2023 | $45.00M – $50.00M | New |
| Feb 23, 2023 | Adjusted EBITDA | FY2023 | $85.00M – $89.00M | New |
| Feb 23, 2023 | Adjusted EBITDA | Q1 FY2023 | $12.00M – $16.00M | New |
| Feb 23, 2023 | Free Cash Flow Generation | FY2023 | $10.00M – $20.00M | New |
| Feb 23, 2023 | Operating Income (Loss) | FY2023 | $17.00M – $22.00M | New |
| Feb 23, 2023 | Operating Income (Loss) | Q1 FY2023 | -$4.00M – $1.00M | New |
| Feb 23, 2023 | R&D | Q1 FY2023 | $8.00M – $9.00M | New |
| Feb 23, 2023 | Stock Based Compensation | FY2023 | $28.00M – $32.00M | Raised |
| Feb 23, 2023 | Depreciation | FY2023 | $24.00M – $26.00M | Lowered |
| Feb 23, 2023 | R&D | FY2023 | $35.00M – $39.00M | New |
| Feb 23, 2023 | Stock Based Compensation | Q1 FY2023 | $7.00M – $8.00M | Raised |
| Feb 23, 2023 | Amortization | Q1 FY2023 | $3.00M – $4.00M | Lowered |
| Feb 23, 2023 | Depreciation | Q1 FY2023 | $6.00M – $7.00M | Lowered |
| Feb 23, 2023 | Operating Cash Flow | FY2023 | $55.00M – $65.00M | Raised |
| Feb 23, 2023 | Amortization | FY2023 | $11.00M – $12.00M | Lowered |
| Feb 23, 2023 | Revenues | Q1 FY2023 | $220.00M – $230.00M | New |
| Feb 23, 2023 | Revenues | FY2023 | $980.00M – $1.00B | New |
| Nov 3, 2022 | Capital Expenditures | FY2022 | $45.00M – $50.00M | Lowered |
| Nov 3, 2022 | Adjusted EBITDA | Q4 FY2022 | $18.00M – $23.00M | New |
| Nov 3, 2022 | Adjusted EBITDA | FY2022 | $70.00M – $75.00M | Lowered |
| Nov 3, 2022 | Free Cash Flow Use | FY2022 | -$80.00M – -$70.00M | Lowered |
| Nov 3, 2022 | Operating Income (Loss) | FY2022 | -$3.00M – $2.00M | Lowered |
| Nov 3, 2022 | Operating Income (Loss) | Q4 FY2022 | $1.00M – $5.00M | New |
| Nov 3, 2022 | R&D | Q4 FY2022 | $8.00M – $10.00M | New |
| Nov 3, 2022 | Operating Cash Flow Use | FY2022 | -$35.00M – -$25.00M | Lowered |
| Nov 3, 2022 | Stock Based Compensation | FY2022 | $26.00M – $27.00M | Raised |
| Nov 3, 2022 | Amortization | FY2022 | $10.00M – $11.00M | Lowered |
| Nov 3, 2022 | Depreciation | FY2022 | $23.00M – $25.00M | Lowered |
| Nov 3, 2022 | R&D | FY2022 | $35.00M – $38.00M | Raised |
| Nov 3, 2022 | Stock Based Compensation | Q4 FY2022 | $6.00M – $7.00M | Raised |
| Nov 3, 2022 | Amortization | Q4 FY2022 | $3.00M – $4.00M | Lowered |
| Nov 3, 2022 | Depreciation | Q4 FY2022 | $7.00M | Lowered |
| Nov 3, 2022 | Revenues | Q4 FY2022 | $231.00M – $251.00M | New |
| Nov 3, 2022 | Revenues | FY2022 | $880.00M – $900.00M | Lowered |
| Nov 3, 2022 | revenue growth | FY2023 | +10% | New |
| Aug 4, 2022 | Capital Expenditures | FY2022 | $45.00M – $55.00M | Lowered |
| Aug 4, 2022 | Adjusted EBITDA | FY2022 | $80.00M – $85.00M | Lowered |
| Aug 4, 2022 | Adjusted EBITDA | Q3 FY2022 | $16.00M – $20.00M | New |
| Aug 4, 2022 | Free Cash Flow Use | FY2022 | -$40.00M – -$30.00M | Reaffirmed |
| Aug 4, 2022 | Operating Income | FY2022 | $13.00M – $18.00M | Lowered |
| Aug 4, 2022 | Operating Income | Q3 FY2022 | $0 – $3.00M | New |
| Aug 4, 2022 | Amortization | FY2022 | $8.00M – $9.00M | Lowered |
| Aug 4, 2022 | R&D | FY2022 | $35.00M – $38.00M | Raised |
| Aug 4, 2022 | R&D | Q3 FY2022 | $9.00M – $10.00M | New |
| Aug 4, 2022 | Depreciation | Q3 FY2022 | $7.00M | Lowered |
| Aug 4, 2022 | Amortization | Q3 FY2022 | $3.00M | Lowered |
| Aug 4, 2022 | Stock Based Compensation | Q3 FY2022 | $6.00M – $7.00M | Raised |
| Aug 4, 2022 | Operating Cash Flow | FY2022 | $15.00M – $25.00M | Lowered |
| Aug 4, 2022 | Stock Based Compensation | FY2022 | $25.00M – $26.00M | Raised |
| Aug 4, 2022 | Depreciation | FY2022 | $24.00M – $25.00M | Lowered |
| Aug 4, 2022 | Revenues | Q3 FY2022 | $220.00M – $230.00M | New |
| Aug 4, 2022 | Revenues | FY2022 | $890.00M – $930.00M | Raised |
| May 5, 2022 | Capital Expenditures | FY2022 | $50.00M – $60.00M | New |
| May 5, 2022 | Adjusted EBITDA | FY2022 | $85.00M – $89.00M | Reaffirmed |
| May 5, 2022 | Adjusted EBITDA | Q2 FY2022 | $11.00M – $14.00M | New |
| May 5, 2022 | Free Cash Flow Use | FY2022 | -$40.00M – -$30.00M | Reaffirmed |
| May 5, 2022 | Operating Income (loss) | Q2 FY2022 | -$3.00M – $0 | New |
| May 5, 2022 | Operating Income (loss) | FY2022 | $26.00M – $30.00M | Lowered |
| May 5, 2022 | Stock Based Compensation | Q2 FY2022 | $6.00M – $7.00M | Raised |
| May 5, 2022 | Operating Cash Flow | FY2022 | $20.00M – $30.00M | New |
| May 5, 2022 | Stock Based Compensation | FY2022 | $25.00M – $26.00M | Raised |
| May 5, 2022 | Amortization | FY2022 | $8.00M – $9.00M | Lowered |
| May 5, 2022 | Depreciation | FY2022 | $24.00M – $25.00M | Lowered |
| May 5, 2022 | R&D | FY2022 | $35.00M – $38.00M | Raised |
| May 5, 2022 | Depreciation | Q2 FY2022 | $5.00M – $6.00M | Lowered |
| May 5, 2022 | Amortization | Q2 FY2022 | $2.00M – $3.00M | Lowered |
| May 5, 2022 | R&D | Q2 FY2022 | $9.00M – $10.00M | New |
| May 5, 2022 | Revenues | Q2 FY2022 | $205.00M – $215.00M | New |
| May 5, 2022 | Revenues | FY2022 | $880.00M – $920.00M | New |
| Feb 22, 2022 | Capital Expenditures | FY2022 | $55.00M – $65.00M | New |
| Feb 22, 2022 | Adjusted EBITDA | Q1 FY2022 | $10.00M – $13.00M | New |
| Feb 22, 2022 | Adjusted EBITDA | FY2022 | $85.00M – $89.00M | New |
| Feb 22, 2022 | Free Cash Flow Use | FY2022 | -$40.00M – -$30.00M | New |
| Feb 22, 2022 | Operating Income (loss) | FY2022 | $27.00M – $31.00M | New |
| Feb 22, 2022 | Operating Income (loss) | Q1 FY2022 | -$3.00M – -$1.00M | New |
| Feb 22, 2022 | Stock Based Compensation | Q1 FY2022 | $7.00M – $8.00M | Raised |
| Feb 22, 2022 | Operating Cash Flow | FY2022 | $25.00M – $35.00M | Raised |
| Feb 22, 2022 | Stock Based Compensation | FY2022 | $28.00M – $29.00M | Raised |
| Feb 22, 2022 | Amortization | FY2022 | $5.00M – $6.00M | Lowered |
| Feb 22, 2022 | Depreciation | FY2022 | $24.00M – $25.00M | Lowered |
| Feb 22, 2022 | R&D | FY2022 | $38.00M – $42.00M | New |
| Feb 22, 2022 | Depreciation | Q1 FY2022 | $5.00M – $6.00M | Lowered |
| Feb 22, 2022 | Amortization | Q1 FY2022 | $1.00M | Lowered |
| Feb 22, 2022 | R&D | Q1 FY2022 | $9.00M – $10.00M | New |
| Feb 22, 2022 | Revenues | Q1 FY2022 | $190.00M – $200.00M | New |
| Feb 22, 2022 | Revenues | FY2022 | $880.00M – $920.00M | New |
| Nov 3, 2021 | Capital Expenditures | FY2021 | $45.00M – $55.00M | New |
| Nov 3, 2021 | Adjusted EBITDA | Q4 FY2021 | $20.00M – $24.00M | New |
| Nov 3, 2021 | Full Year 2021 EBITDA Guidance | FY2021 | $80.00M – $84.00M | New |
| Nov 3, 2021 | free cash flow use from operations | FY2021 | -$30.00M – -$20.00M | New |
| Nov 3, 2021 | Operating Income | Q4 FY2021 | $7.00M – $9.00M | New |
| Nov 3, 2021 | Operating Income | FY2021 | $26.00M – $29.00M | New |
| Nov 3, 2021 | Operating Cash Flow | FY2021 | $25.00M – $30.00M | New |
| Nov 3, 2021 | R&D | FY2021 | $35.00M – $37.00M | Raised |
| Nov 3, 2021 | Depreciation | FY2021 | $21.00M – $22.00M | Lowered |
| Nov 3, 2021 | Stock Based Compensation | FY2021 | $26.00M | Raised |
| Nov 3, 2021 | Amortization | FY2021 | $6.00M – $7.00M | Lowered |
| Nov 3, 2021 | R&D | Q4 FY2021 | $8.00M – $10.00M | New |
| Nov 3, 2021 | Depreciation | Q4 FY2021 | $5.00M – $6.00M | Lowered |
| Nov 3, 2021 | Amortization | Q4 FY2021 | $2.00M | Lowered |
| Nov 3, 2021 | Stock Based Compensation | Q4 FY2021 | $6.00M – $7.00M | Raised |
| Nov 3, 2021 | Revenues | Q4 FY2021 | $205.00M – $215.00M | New |
| Nov 3, 2021 | Revenue | FY2021 | $805.00M – $815.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Kratos Defense & Security Solutions filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- News
- Results
- News
- Results
- Results
- News
- News
- Results
- Results
- Results
- Results
See a number that looks wrong?